195 related articles for article (PubMed ID: 12650835)
21. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
22. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
23. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
24. The cannabinoid CB
Iyer V; Slivicki RA; Thomaz AC; Crystal JD; Mackie K; Hohmann AG
Eur J Pharmacol; 2020 Nov; 886():173544. PubMed ID: 32896549
[TBL] [Abstract][Full Text] [Related]
25. Morphine withdrawal modifies antinociceptive effects of acute morphine in rats.
Dong Z; Mao R; Han H; Cao J; Xu L
Biochem Biophys Res Commun; 2006 Jul; 346(2):578-82. PubMed ID: 16762316
[TBL] [Abstract][Full Text] [Related]
26. Effects of calcitonin gene-related peptide on acute and chronic effects of morphine.
Azarov AV; Szabó G; Czakó L; Telegdy G
Pharmacol Biochem Behav; 1995 Nov; 52(3):595-9. PubMed ID: 8545480
[TBL] [Abstract][Full Text] [Related]
27. Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence.
Naidu PS; Singh A; Joshi D; Kulkarni SK
Addict Biol; 2003 Sep; 8(3):327-36. PubMed ID: 13129835
[TBL] [Abstract][Full Text] [Related]
28. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
29. Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
Elhabazi K; Trigo JM; Mollereau C; Moulédous L; Zajac JM; Bihel F; Schmitt M; Bourguignon JJ; Meziane H; Petit-demoulière B; Bockel F; Maldonado R; Simonin F
Br J Pharmacol; 2012 Jan; 165(2):424-35. PubMed ID: 21718302
[TBL] [Abstract][Full Text] [Related]
30. Role of withdrawal in reinstatement of morphine-conditioned place preference.
Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
[TBL] [Abstract][Full Text] [Related]
31. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
32. The role of formalin-induced pain in morphine tolerance, withdrawal, and reward.
Bardin L; Kim JA; Siegel S
Exp Clin Psychopharmacol; 2000 Feb; 8(1):61-7. PubMed ID: 10743905
[TBL] [Abstract][Full Text] [Related]
33. Effects of capsazepine, a transient receptor potential vanilloid type 1 antagonist, on morphine-induced antinociception, tolerance, and dependence in mice.
Nguyen TL; Nam YS; Lee SY; Kim HC; Jang CG
Br J Anaesth; 2010 Nov; 105(5):668-74. PubMed ID: 20719804
[TBL] [Abstract][Full Text] [Related]
34. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator.
Nakagawa T; Ozawa T; Shige K; Yamamoto R; Minami M; Satoh M
Eur J Pharmacol; 2001 May; 419(1):39-45. PubMed ID: 11348628
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of morphine tolerance and dependence in scopolamine-treated rats.
Zhou H; Ge X; Wang LZ; Ma L; Pei G
Neuroreport; 1999 Jul; 10(10):2007-10. PubMed ID: 10424665
[TBL] [Abstract][Full Text] [Related]
37. Preliminary studies on increased naloxone potency and its relationship to morphine tolerance and dependence in mice.
Wong CL; Wai MK; Roberts MB
Clin Exp Pharmacol Physiol; 1980; 7(3):305-10. PubMed ID: 7190475
[TBL] [Abstract][Full Text] [Related]
38. The role of T-type calcium channels in morphine analgesia, development of antinociceptive tolerance and dependence to morphine, and morphine abstinence syndrome.
Dogrul A; Zagli U; Tulunay FC
Life Sci; 2002 Jun; 71(6):725-34. PubMed ID: 12072160
[TBL] [Abstract][Full Text] [Related]
39. Pioglitazone prevents morphine antinociception tolerance and withdrawal symptoms in rats.
Ghavimi H; Hassanzadeh K; Maleki-Dizaji N; Azarfardian A; Ghasami S; Zolali E; Charkhpour M
Naunyn Schmiedebergs Arch Pharmacol; 2014 Sep; 387(9):811-21. PubMed ID: 24899385
[TBL] [Abstract][Full Text] [Related]
40. The effect of gut microbiome on tolerance to morphine mediated antinociception in mice.
Kang M; Mischel RA; Bhave S; Komla E; Cho A; Huang C; Dewey WL; Akbarali HI
Sci Rep; 2017 Feb; 7():42658. PubMed ID: 28211545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
